Medtronic plc (MDT) FY2026 Q1 P&L / Income Statement

Medtronic plc (MDT) FY2026 Q1 P&L / Income Statement

Income statement for 2025-04-26 through 2025-07-25. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

8,578,000,000 US dollars

Cost of products sold, excluding amortization of intangible assets

3,001,000,000 US dollars

Gross profit (calculated)

5,577,000,000 US dollars

Operating costs, including other operating expenses (calculated)

4,133,000,000 US dollars

Operating profit

1,445,000,000 US dollars

Other income (expense), net (calculated)

negative 143,000,000 US dollars

Income before income taxes

1,302,000,000 US dollars

Income tax provision

255,000,000 US dollars

Net income

1,047,000,000 US dollars

Cardiovascular

3,285,000,000 US dollars

Neuroscience

2,416,000,000 US dollars

Medical Surgical

2,083,000,000 US dollars

Diabetes

721,000,000 US dollars

Other operating segment

33,000,000 US dollars

Rounding (calculated)

1,000,000 US dollars

Research and development expense

726,000,000 US dollars

Selling, general, and administrative expense

2,806,000,000 US dollars

Amortization of intangible assets

459,000,000 US dollars

Restructuring charges, net

45,000,000 US dollars

Certain litigation charges, net

27,000,000 US dollars

Other operating expense, net

70,000,000 US dollars

Revenue before reconciliation (calculated)

8,539,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Other Adjustments

39,000,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to Medtronic plc: $1.04 B; to noncontrolling interests: $7.00 M.

• The amounts that make up operating profit come to $1,444.00 M and operating profit is $1,445.00 M; the $1.00 M difference is within the rounding of the filed amounts.